Gene Therapy Market Research Report By Product (Kymriah, Luxturna, Yescarta, Zolgensma, Strimvelis, Zynteglo), Indication (Oncology, Genetic Diseases) and End-User (Hospitals & Clinics, Specialty Treatment Centers) – Forecast to 2030
The Gene Therapy Market is expected to reach USD 3,251.92 million by 2030 at 19.10% CAGR during the forecast period 2022-2030. A gene, a functional hereditary unit of life, carries an instruction set for a particular function. Gene therapy is the most cutting-edge treatment for blood problems, chronic illnesses, infectious diseases, and cancer. DNA fragment is inserted into the cell using a vector in the process of gene therapy. Due of its target specificity, the major firms are investing in the production of cell and gene therapy medicines. Depending on the type of cells it targets, gene therapy can be divided into two broad categories: somatic gene therapy and germline gene therapy.
Multiple factors, including a strong product pipeline, rising investments by major players, a high prevalence of the target diseases, and the need for cutting-edge drugs, are responsible for the rise of the worldwide gene therapy market. The creation of products is expensive, and strict regulatory standards are anticipated to restrain the market’s expansion. Currently, the global market for gene therapy is dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/8399
Market Segmentation:
The product, indication, and end user segments of the worldwide gene therapy market have been identified.
According to product, the market has been segmented into kymriah, luxturna, yescarta, zolgensma, strimvelis, zynteglo, imlygic, and others.
The global market for gene therapy is divided into three categories based on indication: oncology, genetic diseases/disorders, and others. Due to the high prevalence of cancer and the strong pipeline for cancer gene therapy, the oncology category is anticipated to have the biggest market share and to grow at the fastest rate.
Hospitals & clinics, specialist treatment centres, and others are the market’s end-user segments. Due to the rising number of hospitals, the hospitals & clinics category is anticipated to have the biggest market share. Additionally, hospitals are frequently the primary option for disease treatment.
Regional Analysis:
Americas, Europe, Asia-Pacific, Middle East & Africa, and Asia-Pacific Due to the increasing use of gene therapy and rising per capita healthcare costs, the Americas are anticipated to have the greatest market. North America and Latin America are the two new regions that have been added to the Americas’ gene therapy industry, with the US and Canada making up the majority of the former.
Browse In-depth Market Research Report (111 Pages) on Gene Therapy: https://www.marketresearchfuture.com/reports/gene-therapy-market-8399
Western Europe and Eastern Europe are two subregions of the European gene therapy market. Germany, France, the United Kingdom, Italy, Spain, and the rest of Western Europe have all been added to the list of countries in the Western European market. The Asia-Pacific gene therapy market has been divided into Japan, China, India, South Korea, Australia, and the remainder of Asia-Pacific. due to an increase in patients and more awareness about the treatment methods, the market in Asia-Pacific is expected to be the fastest-growing. The gene therapy market in the Middle East & Africa has been divided into the Middle East and Africa.
Key Players:
Some of the key players in the global gene therapy market are
- Amgen, Inc. (US)
- Novartis AG (Switzerland)
- Spark Therapeutics, Inc. (US)
- Gilead Sciences, Inc. (US)
- uniQure N.V. (Netherlands)
- Orchard Therapeutics plc (UK)
- Celgene Corporation (US)
- Bristol-Myers Squibb Company (US)
- Thermo Fisher Scientific Inc. (US)
- CEVEC (Germany)
- Lonza (Switzerland)
Browse Related Reports at
Gene Editing Market Size, Trends and Insights By Methods (Crispr, Talen, Zfn, Antisense Technology And Others), By Applications (Plant Genetic Engineering, Animal Genetic Engineering, Gene Therapy, Microorganisms Genetic Engineering), By End User (Biotechnology, Pharmaceutical, Contract Research Organization) – Global Forecast Till 2030
Genetic Engineering Market Research Report: Product (Biochemical, Genetic Markers), Devices (PCR, Gene Gun, Gel Assemblies), Techniques (Artificial Selection, Gene Splicing), Application (Agriculture, Medical Industry), End-User- Forecast to 2030
Gene Expression Analysis Market Research Report: Information by Product (Consumables & Instruments), Service (Gene Expression Profiling & Others), Application (Drug Discovery & Others), End User (Academic, Research Institutes & Others) – Forecast till 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com